secwatch.observer — SEC 8-K summary
======================================

Issuer:     Syra Health Corp (SYRA)
CIK:        0001922335
Form:       8-K
Filed at:   2025-08-12T23:59:59+00:00
Accession:  0001641172-25-023118
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Syra Health Q2 net loss narrows 95% to $64K; gross margin surges to 38.7%
-------------------------------------------------------------------------

- Net loss of $64K ($0.01 EPS) vs $1.4M loss ($0.21 EPS) in Q2 2024; adjusted EBITDA improved to ($54K) from ($1.4M).
- Gross margin rose 2,090 bps to 38.7%; operating expenses declined 53% YoY to $816K.
- Population Health revenue up 197% to $1.6M, driven by $5.8M FSSA contract for HCBS training.
- Cash $2.3M, no long-term debt; negotiating $5.8M CMHW mental health contract with Indiana FSSA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1922335/000164117225023118/0001641172-25-023118-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1922335/000164117225023118/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-023118

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer